Creatinine Clearance Calculator
Free Creatinine Clearance Calculator
Estimate kidney function using the Cockcroft-Gault EquationCrCl = [(140−Age) × Weight × (0.85 if female)] / (72 × SCr)
Calculation Results
Clinical Interpretation
Results will appear here after calculation.
CKD Stages Reference (KDIGO Guidelines)
| Stage | GFR Range | Description |
|---|---|---|
| Stage 1 | ≥90 mL/min | Normal or high kidney function |
| Stage 2 | 60-89 mL/min | Mildly decreased function |
| Stage 3a | 45-59 mL/min | Mild to moderate decrease |
| Stage 3b | 30-44 mL/min | Moderate to severe decrease |
| Stage 4 | 15-29 mL/min | Severely decreased function |
| Stage 5 | <15 mL/min | Kidney failure (ESRD) |
Kidney Function Calculators
Estimate GFR using validated clinical equationsCreatinine Clearance (Cockcroft-Gault)
Estimates creatinine clearance (CrCl) in mL/min. Commonly used for drug dosing adjustments.CrCl = [(140 - Age) × Weight × (0.85 if female)] / (72 × SCr)
Results
Results will appear here.
eGFR Calculator (CKD-EPI 2021)
Race-free equation recommended by NKF/ASN for estimating GFR. Best for CKD staging.eGFR = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^-1.200 × 0.9938^Age × (1.012 if female)
Results
Results will appear here.
MDRD GFR Calculator
4-variable MDRD equation (race-free modification). Historical reference equation.GFR = 175 × SCr^-1.154 × Age^-0.203 × (0.742 if female)
Results
Results will appear here.
Clinical Support Tools
Essential calculators and references for healthcare professionalsBody Weight Calculators
Calculate Ideal Body Weight (IBW), Adjusted Body Weight (ABW), and Body Surface Area (BSA)Calculation Results
• IBW (Devine formula): Use for drug dosing in underweight patients
• ABW: Use for aminoglycoside and vancomycin dosing in obese patients (>120% IBW)
• BSA (Mosteller): Use for chemotherapy dosing and normalizing GFR
Creatinine Unit Converter
Convert serum creatinine between mg/dL and µmol/Lmg/dL → µmol/L
µmol/L → mg/dL
• µmol/L = mg/dL × 88.4
• mg/dL = µmol/L ÷ 88.4
Reference Ranges:
• Male: 0.7-1.3 mg/dL (62-115 µmol/L)
• Female: 0.6-1.1 mg/dL (53-97 µmol/L)
CKD Stages Reference (KDIGO 2024)
Chronic Kidney Disease classification based on GFR and albuminuriaGFR Categories
| Category | GFR (mL/min/1.73m²) | Description | Clinical Action |
|---|---|---|---|
| G1 | ≥90 | Normal or high | Diagnose CKD if other markers present; treat comorbidities |
| G2 | 60-89 | Mildly decreased | Estimate progression; monitor annually |
| G3a | 45-59 | Mild to moderate decrease | Consider nephrology referral; adjust medications |
| G3b | 30-44 | Moderate to severe decrease | Monitor q3-6 months; assess complications |
| G4 | 15-29 | Severely decreased | Refer to nephrology; plan RRT if needed |
| G5 | <15 | Kidney failure (ESRD) | Initiate RRT (dialysis/transplant) when indicated |
Albuminuria Categories (ACR)
| Category | ACR (mg/g) | Description |
|---|---|---|
| A1 | <30 | Normal to mildly increased |
| A2 | 30-300 | Moderately increased (microalbuminuria) |
| A3 | >300 | Severely increased (macroalbuminuria) |
• CKD is defined as GFR <60 mL/min/1.73m² OR kidney damage markers for ≥3 months
• Both GFR and albuminuria should be used for CKD staging and prognosis
• Higher albuminuria = faster progression and higher cardiovascular risk
• Reference: KDIGO 2024 Clinical Practice Guideline for CKD
Creatinine Clearance Explained
Efficient estimation of kidney function is essential for clinical practice, and the creatinine clearance calculator provides a practical and user-friendly tool for estimating GFR by applying the Cockcroft-Gault equation (or measures based on other formulas) to serum creatinine along with other factors like age, weight, and gender in estimating CrCl for drug dose adjustment or to get a picture of renal function for nephrology consult.
CrCl is used in fields where GFR has not been directly measured, because the meaasurement of GFR can be complex and is not readily practical for daily use, with serum creatinine and estimated creatinine clearance being the most widely used methods in clinical practice.
Why Is CrCl Important for Drug Dosing Economics?
Accurate prediction of creatinine clearance is pivotal in dosing adjustments of medications and avoiding toxicity in the setting of renal dysfunction. The Cockcroft-Gault formula continues to be the standard reference in various narrative drug-dosing guidelines and regulatory labels. The earlier clinical trials and FDA approval labels are based on this formula, not on eGFR methods such as CKD-EPI or MDRD.
What is Creatinine Clearance?
Creatinine clearance is the volume of plasma that is cleared of creatinine over time, based on the creatinine levels in the blood, and how the kidneys are processing it through the nephron. As creatinine is produced by the body at a constant rate, a blood test for creatinine is a more practical way of estimating creatinine clearance than performing the cumbersome 24-hour urine collection test.
This clearance estimate from the Cockcroft-Gault equation is an approximation of the glomerular filtration rate (GFR) with the understanding that a small amount of creatinine is secreted in the renal tubules. A creatinine clearance calculator uses this equation, and it will estimate CrCl in mL/min from age, sex, and body weight.
CrCl vs. Measured GFR
CrCl is often used in clinical cases because it is convenient and is more than adequate for renal dosing, even though it is slightly less than the actual GFR. This, along with the fact that it very slightly overestimates GFR, is the reason for its value in clinical technology.
Clinical Applications
National Kidney Foundation (NKF) recommendations for risk stratification, chronic kidney disease (CKD) staging, clinical longitudinal renal function assessment, and cross-sectional renal function assessment involve the use of CrCl for dosing.
Understanding the Cockcroft-Gault Equation
The Cockcroft-Gault equation is the most frequently used and most cited equation in estimating creatinine clearance from serum creatinine, and it is the most frequently used equation in clinical practice. The equation uses age, sex, weight, and serum creatinine and it has many disciples because it is based on the most validated research of any of the serum creatinine to estimated creatinine clearance equations.
The equation for calculating CrCl is as follows:
CrCl Equation Terms
The Gault equation combines the fundamental components that affect the clearance and generation of creatinine that comprise the following factors:
Age
Represents the progressive loss of renal function with agingGender
Represents the differences in average muscle mass for men and womenSerum Creatinine
Represents the biochemical value that corresponds to kidney filtration rateBody Weight
Represents the surrogate for creatinine production (can be actual, ideal, or adjusted weight)Weight Selection Criteria
The choice of using actual body weight, ideal body weight, or adjusted weight can differ between institutions based on body composition and policies:
| Weight Type | When to Use | Considerations |
|---|---|---|
| Actual Body Weight | Most patients within normal BMI | May give a CrCl overestimation in Obese Patients |
| Ideal Body Weight | Obese patients (>120% IBW) | May give a CrCl Underestimation in Underweight patients |
| Adjusted Body Weight | Patients with significant Obesity | ABW = IBW + 0.4 × (Actual − IBW) |
How to Use the Creatinine Clearance Calculator
Using a creatinine clearance calculator begins with gathering accurate inputs that drive the equation. Follow these steps to obtain an estimated creatinine clearance for kidney function assessment and drug dosing guidance.
Step-by-Step Guide
Obtain serum creatinine
Confirm the creatinine values are up-to-date and verify the unit (mg/dL or μmol/L for SI units). The calculator will harmonize units for the equation.
Enter patient demographics
Input age (years) and select biological sex. These factors significantly impact the prediction of creatinine clearance.
Choose weight basis
Select actual body weight for most patients, ideal body weight when obesity is present, or adjusted methods per institutional guidance.
Calculate CrCl
The calculator executes the Cockcroft-Gault equation derived by Cockcroft DW and Gault MH to generate your result.
Review and interpret
Examine the estimated creatinine clearance output (CrCl, mL/min). If needed, repeat using alternative weight assumptions to test sensitivity.
Best Practice Tip
Document your assumptions (weight type, serum creatinine timing) because they affect kidney function interpretation and drug dosing decisions. Compare with eGFR from CKD-EPI or MDRD to contextualize results.
Understanding Results from the Calculator
The CrCl result gives an estimate for creatinine clearance at the glomerular filtration rate at the nephron level. It is important for you to understand the value of these and how one interprets them.
Ranges of CrCl and Their Clinical Importance
| CrCl (mL/min) | Kidney Function Stage | Dosing Considerations (Drugs) |
|---|---|---|
| >90 | Normal kidney function | Standard dosing usually fine |
| 60-89 | Reduction 1 | Monitor; dosing of some drugs may need to be adjusted |
| 30-59 | Reduction 2 | Dosing reduction is needed |
| 15-29 | Reduction 3 | Significant dosing changes needed |
| <15 | Kidney failure | High possibility of needing to consider dialysis |
Differentiating CrCl and eGFR
CrCl and eGFR differ. If so, the National Kidney Foundation's recommendations about body composition, dynamic changes in serum creatinine, and the estimation of creatinine clearance and the risk stratification may also need to be adjusted.
Primary Differences Between eGFR and Creatinine Clearance
It is important to understand eGFR and creatinine clearance for clinical use. Clinically, both have the same function of estimating renal function, but each serves a different function.
| Feature | CrCl (Cockcroft-Gault) | eGFR (CKD-EPI/MDRD) |
|---|---|---|
| Output Units | mL/min (absolute) | mL/min/1.73m² (BSA-normalized) |
| Primary Use | Drug dosing | Kidney disease staging |
| Weight Factor | Includes body weight | Does not include weight |
| FDA Drug Labels | Most commonly referenced | Increasingly used |
| Obesity Handling | Requires weight adjustment | Less affected by body size |
When to Use Each Method
Cockcroft-Gault CrCl should be used when drug labels specifically mention creatinine clearance. CKD-EPI eGFR should be used for kidney disease staging and for monitoring over time as recommended by the National Kidney Foundation.
Common Mistakes to Avoid
There are several pitfalls that need to be considered for accurate estimations of creatinine clearance. Each of these issues needs to be avoided in order to ensure that the results are reliable for the clinical decision-making process.
Unit Errors
Entering values of serum creatinine in the wrong units leads to wrong estimates of CrCl. Units need to be double checked before the calculations are done.
Weight Misapplication
Using actual body weight in the case of obese patients can greatly and inappropriately overestimate renal function. Use the ideal body weight or the adjusted body weight.
Unstable Creatinine
Using only one estimate in a case where the value(s) of creatinine is (are) rapidly changing (acute kidney injury) is an unreliable way to determine the CrCl.
CrCl/eGFR Interchange
Disregarding the Cockcroft-Gault framework when drug dosing by interchanging eGFR and CrCl is not the way to go when the labels say to use the Cockcroft-Gault.
Limitations of the Cockcroft-Gault Equation
In spite of its many uses, the Cockcroft-Gault equation has recognizably negative attributes which clinicians should be aware of when utilizing a calculator that measures a patient's creatinine clearance.
Frequently Asked Questions
Common questions about creatinine clearance calculations and clinical applications
The term crcl (creatinine clearance) refers to an estimate of the number of blood constituents the kidneys clear of creatinine in a minute and is most often calculated using a creatinine clearance calculator. These calculators utilize the Cockcroft and Gault equation and/or some modifications of the MDRD (Modification of Diet in Renal Disease) and Levey-derived serum creatinine to glomerular filtration rate estimating functions to aid in the dosing and assessment of renal function.
Estimating renal function using the Cockcroft and Gault equation involves estimating renal clearance of creatinine by using serum creatinine level along with the patient's age, weight, and sex. The equation was the first (and most) widely used to estimate CrCl in patients for drug dosing (like dosing of aminoglycosides) and continues to be cited in clinical guides, though its accuracy is dependent on the population and body composition.
Yes, using total body weight would give a biased estimate of Cockcroft and Gault if total body weight is used. Because dosing for pharmacokinetics is often performed using adjusted body weight or lean body weight, many practitioners in the field of clinical pharmacokinetics dosing prefer using adjusted body weight. Clinical judgement and recommendations for the specific drug in question should guide the decision as to whether total, ideal, or adjusted body weight will be used, as body weights and serum creatinine concentrations will interact to have an effect on the creatinine clearance estimate.
Estimating renal function for elderly patients using Cockcroft-Gault can be difficult as for the elderly patients the low serum creatinine does not imply reduced muscle mass and therefore renal function is overestimated, as the muscle mass is low. Although the Cockcroft Gault and the study equation adaptations used to estimate renal function in the elderly attempts to factor in age, additional measures or methods are used (including those from Levey and colleagues) to estimate renal function in the elderly and there is a clinical context that is factored into the estimation.
Calculating serum creatinine assumes equilibrium within the serum creatinine levels. This will not be the case when renal function is unstable (i.e. rapidly changing with each iteration). When serum creatinine levels are low, as is the case with muscle mass depletion, or cachexia, the reliability of the crcl estimations suffers leading to a biased calculative GFR estimate.
MDRD or Levey-derived equations estimate GFR in relation to body surface area and may perform better than Cockcroft-Gault for chronic kidney disease staging in some populations. However, MDRD and CKD-EPI (also derived by Levey) use serum creatinine standardised assays and are often preferred for estimating GFR from serum in chronic kidney disease, while crcl from Cockcroft-Gault is still widely used to make drug dosing recommendations.
In research settings, discrepant clinical scenarios, unstable renal function, body surface area extremes (very obese or very cachectic), and when aminoglycosides and other high-risk drugs are being dosed, measured creatinine clearance (24-hour urine collection) or direct GFR measurement should be used above calculated CrCl. Journals such as J Kidney Dis and J Health Syst Pharm have analyzed equation limitations and the accuracy of measured versus estimated values.
Body weight and serum creatinine impact crcl estimates and serum creatinine levels indicate muscle mass and creatinine production. Overestimation of renal function is often the result of low muscle mass (and hence low serum creatinine levels). On the other hand, obesity has a tendency to inflate weight dependent estimates. Use of standard creatinine assays (e.g. Coresh initiatives and others for lab standardization) improved comparability and bias for the calculation of renal clearance using adjustments like adjusted body weight, BSA standardization, and others.

